Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

PET study of changes in [11C]AZ14132516 uptake following administration of AZD7798 to healthy participants and patients with Crohn’s disease

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Other

Sponsor

Astrazeneca AB

Enrolment target

14

Start

31 Aug 2023

Crohn's Disease

Who may be eligible?

Age 18 Years to any · Sex: All

Locations (1)

—
Sweden

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.